CVS HEALTH CORPORATION Impairment of Long-Lived Assets to be Disposed of
CVS HEALTH CORPORATION (CVS) reported Impairment of Long-Lived Assets to be Disposed of of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-10.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf · last filed 2026-02-10
- CVS HEALTH CORPORATION impairment of long-lived assets to be disposed of for the quarter ending 2024-12-31 was $0.00.
- CVS HEALTH CORPORATION impairment of long-lived assets to be disposed of for the quarter ending 2024-09-30 was $0.00.
- CVS HEALTH CORPORATION impairment of long-lived assets to be disposed of for the quarter ending 2024-06-30 was $0.00.
- CVS HEALTH CORPORATION impairment of long-lived assets to be disposed of for the quarter ending 2024-03-31 was $0.00, a 100.00% decline year-over-year.
- CVS HEALTH CORPORATION impairment of long-lived assets to be disposed of for fiscal 2025 was $0.00.
- CVS HEALTH CORPORATION impairment of long-lived assets to be disposed of for fiscal 2024 was $0.00, a 100.00% decline from fiscal 2023.
- CVS HEALTH CORPORATION impairment of long-lived assets to be disposed of for fiscal 2023 was $349.00M, a 86.22% decline from fiscal 2022.
- CVS HEALTH CORPORATION impairment of long-lived assets to be disposed of for fiscal 2022 was $2.53B.
| Period end | Impairment of Long-Lived Assets to be Disposed of 3 month | Impairment of Long-Lived Assets to be Disposed of 6 month | Impairment of Long-Lived Assets to be Disposed of 9 month | Impairment of Long-Lived Assets to be Disposed of 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-02-10 | |||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-10 | $0.00 derived: sum of 2 quarters · filed 2026-02-10 | $0.00 derived: sum of 3 quarters · filed 2026-02-10 | $0.00 10-K · filed 2026-02-10 |
| 2024-09-30 | $0.00 10-Q · filed 2024-11-06 | $0.00 derived: sum of 2 quarters · filed 2024-11-06 | $0.00 10-Q · filed 2024-11-06 | $0.00 derived: sum of 4 quarters · filed 2026-02-10 |
| 2024-06-30 | $0.00 10-Q · filed 2024-08-07 | $0.00 10-Q · filed 2024-08-07 | $0.00 derived: sum of 3 quarters · filed 2026-02-10 | $0.00 derived: sum of 4 quarters · filed 2026-02-10 |
| 2024-03-31 | $0.00 10-Q · filed 2024-05-01 | $0.00 derived: sum of 2 quarters · filed 2026-02-10 | $0.00 derived: sum of 3 quarters · filed 2026-02-10 | $0.00 derived: sum of 4 quarters · filed 2026-02-10 |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-10 | $0.00 derived: sum of 2 quarters · filed 2026-02-10 | $0.00 derived: sum of 3 quarters · filed 2026-02-10 | $349.00M 10-K · filed 2026-02-10 |
| 2023-09-30 | $0.00 10-Q · filed 2024-11-06 | $0.00 derived: sum of 2 quarters · filed 2024-11-06 | $349.00M 10-Q · filed 2024-11-06 | $361.00M derived: sum of 4 quarters · filed 2025-02-12 |
| 2023-06-30 | $0.00 10-Q · filed 2024-08-07 | $349.00M 10-Q · filed 2024-08-07 | $361.00M derived: sum of 3 quarters · filed 2025-02-12 | $2.84B derived: sum of 4 quarters · filed 2025-02-12 |
| 2023-03-31 | $349.00M 10-Q · filed 2024-05-01 | $361.00M derived: sum of 2 quarters · filed 2025-02-12 | $2.84B derived: sum of 3 quarters · filed 2025-02-12 | $2.84B derived: sum of 4 quarters · filed 2025-02-12 |
| 2022-12-31 | $12.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-12 | $2.49B derived: sum of 2 quarters · filed 2025-02-12 | $2.49B derived: sum of 3 quarters · filed 2025-02-12 | $2.53B 10-K · filed 2025-02-12 |
| 2022-09-30 | $2.48B 10-Q · filed 2023-11-01 | $2.48B derived: sum of 2 quarters · filed 2023-11-01 | $2.52B 10-Q · filed 2023-11-01 | $2.52B derived: sum of 4 quarters · filed 2024-02-07 |
| 2022-06-30 | $0.00 10-Q · filed 2023-08-02 | $41.00M 10-Q · filed 2023-08-02 | $41.00M derived: sum of 3 quarters · filed 2024-02-07 | $41.00M derived: sum of 4 quarters · filed 2024-02-07 |
| 2022-03-31 | $41.00M 10-Q · filed 2023-05-03 | $41.00M derived: sum of 2 quarters · filed 2024-02-07 | $41.00M derived: sum of 3 quarters · filed 2024-02-07 | $41.00M derived: sum of 4 quarters · filed 2024-02-07 |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-07 | $0.00 derived: sum of 2 quarters · filed 2024-02-07 | $0.00 derived: sum of 3 quarters · filed 2024-02-07 | $0.00 10-K · filed 2024-02-07 |
| 2021-09-30 | $0.00 10-Q · filed 2022-11-02 | $0.00 derived: sum of 2 quarters · filed 2022-11-02 | $0.00 10-Q · filed 2022-11-02 | |
| 2021-06-30 | $0.00 10-Q · filed 2022-08-03 | $0.00 10-Q · filed 2022-08-03 | ||
| 2021-03-31 | $0.00 10-Q · filed 2022-05-04 | |||
| 2020-12-31 | $0.00 8-K · filed 2023-05-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PETMED EXPRESS INC (PETS) | United States | $0.034B | -1.41 |